Tear organic acid analysis after corneal collagen crosslinking in keratoconus
dc.authorid | 0000-0002-3053-2396 | |
dc.contributor.author | Sağlık, Ayhan | |
dc.contributor.author | Koyuncu, İsmail | |
dc.contributor.author | Soydan, Adem | |
dc.contributor.author | Sağlık, Ferdağ | |
dc.contributor.author | Gönel, Ataman | |
dc.date.accessioned | 2021-06-23T19:54:27Z | |
dc.date.available | 2021-06-23T19:54:27Z | |
dc.date.issued | 2020 | |
dc.department | BAİBÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Objectives: This study examined changes in the levels of organic acids, which are important tear metabolites, after corneal collagen crosslinking (CXL) treatment for keratoconus. Methods: This prospective, nonrandomized, interventional case series included a single eye from 24 patients who were scheduled to receive CXL treatment (Dresden protocol) for progressive keratoconus. Before CXL treatment and at 6 months after treatment, tears were collected in capillary tubes. The patients were separated into four groups as males, females, and ages 18 years younger and >18 older. The organic acid profiles of the tear samples were analyzed using mass spectrometry. Results: An evaluation was made of 12 females and 12 males with a mean age of 19.20 +/- 4.06 years (range: 12-27 years). The greatest percentage increase in organic acids after CXL treatment was observed for N-acetyl-L-aspartic acid (66% increase). The organic acid showing the greatest decrease was 3-OH butyric acid (61% decrease). A decrease of 46% was found (P=0.263) in the lactic acid/malic acid ratio. Conclusion: Metabolomic studies of tears could facilitate a new and objective process in the follow-up period or in the determination of prognosis after CXL treatment for diseases such as keratoconus, which has a multifactorial etiology. | en_US |
dc.identifier.doi | 10.1097/ICL.0000000000000644 | |
dc.identifier.endpage | S128 | en_US |
dc.identifier.issn | 1542-2321 | |
dc.identifier.issn | 1542-233X | |
dc.identifier.pmid | 31425352 | en_US |
dc.identifier.scopus | 2-s2.0-85081942150 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | S122 | en_US |
dc.identifier.uri | https://doi.org/10.1097/ICL.0000000000000644 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/10549 | |
dc.identifier.volume | 46 | en_US |
dc.identifier.wos | WOS:000570962600009 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Soydan, Adem | |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Eye & Contact Lens-Science And Clinical Practice | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Organic Acids | en_US |
dc.subject | Metabolomics | en_US |
dc.subject | Keratoconus | en_US |
dc.subject | Crosslinking | en_US |
dc.subject | Tears Metabolites | en_US |
dc.title | Tear organic acid analysis after corneal collagen crosslinking in keratoconus | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- ayhan-saglik.pdf
- Boyut:
- 588.65 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text